← Back to Search

Goal Management Training (GMT) for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Ruth A. Lanius, MD, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if Goal Management Training (GMT) can help adults with PTSD, including COVID-19 frontline workers, improve their thinking skills. GMT teaches strategies for better goal and task management. Participants will either start GMT right away or wait for a few months before beginning the program. GMT is designed to improve attention and thinking skills.

Eligible Conditions
  • Post Traumatic Stress Disorder
  • Cognitive Impairment
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Clinician Administered PTSD Scale (CAPS) score from baseline to post-treatment assessment
Change in Clinician Administered PTSD Scale (CAPS) score from post-treatment to 3-month follow-up assessment
Change in Difficulties in Emotion Regulation Scale (DERS) score from baseline to post-treatment assessment
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Goal Management Training (GMT)Experimental Treatment1 Intervention
Participants in this arm will attend 9 weekly, 2-hour group GMT appointments.
Group II: Wait ListActive Control1 Intervention
Participants in this arm will receive no treatment for approximately 21 weeks (at which point, they will be offered the same, standard GMT treatment).

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
676 Previous Clinical Trials
416,643 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,382 Previous Clinical Trials
26,514,795 Total Patients Enrolled
FDC FoundationOTHER
2 Previous Clinical Trials
11 Total Patients Enrolled
~0 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top